COMMUNIQUÉS West-GlobeNewswire

Teladoc Announces Proposed Sale of Shares of Common Stock

23/07/2018 - 22:40

PURCHASE, NY, July 23, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE:TDOC) (“Teladoc”) today announced a proposed sale of shares of its common stock, which includes 5,000,000 shares offered by Teladoc and 263,740 shares [...]

Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock

23/07/2018 - 22:39

IRVING, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced its intention to offer and sell 3,000, [...]

Vericel to Report Second-Quarter 2018 Financial Results on August 6, 2018

23/07/2018 - 22:36

CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and [...]

Akcea Therapeutics to Hold Second Quarter 2018 Financial Results Webcast

23/07/2018 - 22:30

Webcast scheduled for Monday, August 6th at 4:30 p.m. Eastern Time CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today [...]

Medigus Announces Closing of $10 Million Public Offering

23/07/2018 - 22:05

OMER, Israel, July 23, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”)(NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct [...]

Establishment Labs Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Common Shares

23/07/2018 - 22:05

NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the closing [...]

Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

23/07/2018 - 22:02

STAMFORD, Conn., July 23, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]

TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007

23/07/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - July 23, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]

Lexicon Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018

23/07/2018 - 22:01

THE WOODLANDS, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), will release its second quarter 2018 financial results on Monday, July 30, 2018 before market opens. Management will [...]

Genesis HealthCare Expects to Release Second Quarter 2018 Results on August 7, 2018

23/07/2018 - 22:01

KENNETT SQUARE, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE:GEN) (Genesis or the Company), one of the nation’s largest providers of post-acute care, today announced that it expects to release its [...]

Merit Medical Reports Record Revenues for Second Quarter of 2018; Merit Adjusts 2018 Guidance

23/07/2018 - 22:01

Q2 2018 worldwide revenue of $224.8 million ($221.2 million on a comparable, constant currency* basis), up 20.5% as reported (up 18.6% on a comparable, constant currency* basis) over Q2 2017 Q2 2018 core revenue* up 11. [...]

GW Pharmaceuticals to Report Third Quarter Financial Results and Host Conference Call on 7 August, 2018

23/07/2018 - 22:00

LONDON, July 23, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]

Micron Products, Inc. wins multi-year purchase commitment for components used by the U.S. Armed Forces

23/07/2018 - 21:22

FITCHBURG, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Micron Products, Inc., a wholly owned subsidiary of Micron Solutions, Inc.(NYSE American:MICR), (together “Micron” or “the Company”) ”) announced today that the [...]

Major shareholder notification – T. Rowe Price Group, Inc.

23/07/2018 - 21:11

GN Store Nord has received information that T. Rowe Price Group, Inc. has decreased its holdings of GN shares. T. Rowe Price Group, Inc. thereby holds less than 5% of the share capital and the voting rights. For further [...]

Cognition Therapeutics Presents Additional Elayta™ Clinical Results during Alzheimer's Association International Conference (AAIC) Symposium Session

23/07/2018 - 20:19

Pittsburgh, July 23, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics , Inc. , a clinical stage neuroscience company focused on synaptic health and restoration in neurodegenerative disorders, today announced that co- [...]

Pacific Biosciences of California, Inc. Second Quarter 2018 Financial Results Call

23/07/2018 - 20:11

MENLO PARK, Calif., July 23, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) will hold its quarterly conference call to discuss its Second Quarter 2018 Financial Results on Thursday, [...]

AB Science reports positive IDMC recommendation to continue the study based on a trend analysis of the masitinib phase 2/3 study in refractory metastatic colorectal cancer

23/07/2018 - 19:02

Paris, July 23, 2018, 7pm AB Science reports positive IDMC recommendation to continue the study based on a trend analysis of the masitinib phase 2/3 study in refractory metastatic colorectal cancer AB Science SA (NYSE [...]

AB Science annonce que l'IDMC a recommandé la poursuite de l'étude de phase 2/3 du masitinib dans le cancer colorectal métastatique réfractaire, sur la base de l'analyse de tendance

23/07/2018 - 19:02

Paris, 23 juillet 2018, 19h AB Science annonce que l'IDMC a recommandé la poursuite de l'étude de phase 2/3 du masitinib dans le cancer colorectal métastatique réfractaire, sur la base de l'analyse de tendance AB [...]

Konica Minolta Healthcare Demonstrates Leadership in Medical Imaging Solutions for the Continuum of Care

23/07/2018 - 18:57

WAYNE, N.J., July 23, 2018 (GLOBE NEWSWIRE) -- As the US healthcare market continues to shift toward larger, integrated health systems in an increasingly decentralized clinical environment, hospitals are investing in [...]